6330 N Andrews Ave #274 Fort Lauderdale, Florida 33309, UNITED STATES
Always Open
About
We carry popular Mitragyna Speciosa such as Red Vein Maeng Da, Green Vein Maeng Da, Red Vein Bali, Malay, Sumatra.
Our Presentation: Kratom Powder, Kratom Capsules, Kratom Extracts
Premium Brands: OPMS More
Kratom-Pharmacology, Clinical Implications and Deep Review
The prevalence of kratom use appears to be increasing in Europe and North America, raising concerns for its possible development into a significant public health threat.
The body of scientific literature concerning kratom is expanding, but has not yet sufficiently characterized the nature and extent of the potential risks posed by kratom.
There is an increasing need for healthcare providers to be familiar with kratom and the management of patients who abuse it.
What is Kratom? - National Institute of Health overview of Kratom
“Kratom” commonly refers to an herbal substance that can produce opioid- and stimulant-like effects. Kratom and kratom-based products are currently legal and accessible in many areas, though U.S. and international agencies continue to review emerging evidence to inform kratom policy.
While there are no uses for kratom approved by the U.S. Food and Drug Administration, people report using kratom to manage drug withdrawal symptoms and cravings (especially related to opioid use), pain, fatigue and mental health problems. NIDA supports and conducts research to evaluate potential medicinal uses for kratom and related chemical compounds.
Maeng Da Kratom – Strain Information, Effects, & Review
Even the most seasoned kratom users are often uneducated about the Maeng Da strain. Since Maeng Da is one of the newest strains to hit the market, it’s less understood than most other strains that have been around for centuries.
But Maeng Da has quickly grown in popularity since its introduction to the market, with many people using the product to alleviate pain, drowsiness, and even anxiety.
Respiratory effects of oral mitragynine and oxycodone in a rodent model.
Compare the respiratory effects of oral mitragynine to oral oxycodone in rats for evaluating effects of opioids
Consistent with mitragynine’s pharmacology that includes partial µ-opioid receptor agonism with little recruitment of the respiratory depressant activating β-arrestin pathway, mitragynine produced no evidence of respiratory depression at doses many times higher than known to be taken by humans.
atai Life Sciences - Phase 1 trial of kratom-derived pharmaceutical
atai and Kures are poised to address two key factors underlying the opioid epidemic developing a potentially safer and more widely available alternative for both pain management and opioid maintenance therapy.
One of the leading therapeutic indicators of kratom is its analgesic effect. One study of Kratom users in Malaysia showed that 90% were using kratom as a substitute for opioids, with 84% reporting that kratom eased their opioid withdrawal symptoms.
